Balance Sheet
Cash Flow Statement
Beginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

BioScience Health Innovations (BHIC) Preferred Shares Issued (2021 - 2022)

BioScience Health Innovations has reported Preferred Shares Issued over the past 2 years, most recently at $40000.0 for Q4 2022.

  • Quarterly Preferred Shares Issued fell 60.0% to $40000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $40000.0 through Nov 2022, down 60.0% year-over-year, with the annual reading at $100000.0 for FY2022, N/A changed from the prior year.
  • Preferred Shares Issued was $40000.0 for Q4 2022 at BioScience Health Innovations, down from $100000.0 in the prior quarter.
  • Over five years, Preferred Shares Issued peaked at $100000.0 in Q4 2021 and troughed at $40000.0 in Q4 2022.